. (ECYT)
$23.99 - (-)
Market Cap: -
As of 02/15/19 12:00 AM EST. Market closed.
. (ECYT)
$23.99
- (-)
Market Cap: -
As of 02/15/19 12:00 AM EST. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
CEO Compensation (Base)
$435,385
CEO Compensation (Total)
$1.83M
URL
Address
.
Sector
Industry
CEO Compensation (Base)
$435,385
CEO Compensation (Total)
$1.83M
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$23.99
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$23.99
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 904,465 | 21,707,160 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 267,491 | 6,419,784 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 8,434 | 202,416 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 1,212,413 | 29,097,912 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 10,049 | 241,176 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 1,017,304 | 24,415,296 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 100,828 | 2,419,872 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 113,489 | 2,723,736 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 113,315 | 2,719,560 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 162,170 | 3,892,080 | 0 | Dec 21, 2018, 12:54 PM |
MIDDLETON FRED A | Director | Dec 21, 2018 | Option Exercise | $24.00 | 249,148 | 5,979,552 | 0 | Dec 21, 2018, 12:54 PM |
Machado Patrick | Director | Dec 21, 2018 | Option Exercise | $24.00 | 7,050 | 169,200 | 0 | Dec 21, 2018, 12:54 PM |
McAvoy David R. | General Counsel | Dec 21, 2018 | Option Exercise | $24.00 | 25,869 | 620,856 | 0 | Dec 21, 2018, 12:53 PM |
Leamon Christopher P | Vice President of Research | Dec 21, 2018 | Option Exercise | $24.00 | 224,256 | 5,382,144 | 0 | Dec 21, 2018, 12:53 PM |
Armour Alison A. | Chief Medical Officer | Dec 21, 2018 | Option Exercise | $24.00 | 10,500 | 252,000 | 0 | Dec 21, 2018, 12:53 PM |
Armour Alison A. | Chief Medical Officer | Dec 21, 2018 | Option Exercise | $24.00 | 139,753 | 3,354,072 | 0 | Dec 21, 2018, 12:53 PM |
Parker Katherine | VP of Human Resources | Dec 21, 2018 | Option Exercise | $24.00 | 1,200 | 28,800 | 0 | Dec 21, 2018, 12:53 PM |
Parker Katherine | VP of Human Resources | Dec 21, 2018 | Option Exercise | $24.00 | 62,797 | 1,507,128 | 0 | Dec 21, 2018, 12:53 PM |
Russell Lesley | Director | Dec 21, 2018 | Option Exercise | $24.00 | 11,100 | 266,400 | 0 | Dec 21, 2018, 12:52 PM |
Chelius Erik C. | Vice President CMC | Dec 21, 2018 | Option Exercise | $24.00 | 49,895 | 1,197,480 | 0 | Dec 21, 2018, 12:51 PM |
APLIN JOHN C | Director | Dec 21, 2018 | Option Exercise | $24.00 | 32,163 | 771,912 | 0 | Dec 21, 2018, 12:51 PM |
Taylor Beth | VP Finance & Chief Acctg Off | Dec 21, 2018 | Option Exercise | $24.00 | 1,250 | 30,000 | 0 | Dec 21, 2018, 12:49 PM |
Taylor Beth | VP Finance & Chief Acctg Off | Dec 21, 2018 | Option Exercise | $24.00 | 98,259 | 2,358,216 | 0 | Dec 21, 2018, 12:49 PM |
GODDARD COLIN | Director | Dec 21, 2018 | Option Exercise | $24.00 | 11,100 | 266,400 | 0 | Dec 21, 2018, 12:49 PM |
Svoronos Dawn | Director | Dec 21, 2018 | Option Exercise | $24.00 | 7,050 | 169,200 | 0 | Dec 21, 2018, 12:48 PM |
KOZIN MARC D | Director | Dec 21, 2018 | Option Exercise | $24.00 | 11,100 | 266,400 | 0 | Dec 21, 2018, 12:48 PM |
Sherman Michael A. | President and CEO | Dec 21, 2018 | Option Exercise | $24.00 | 19,919 | 478,056 | 0 | Dec 21, 2018, 12:47 PM |
Sherman Michael A. | President and CEO | Dec 21, 2018 | Option Exercise | $24.00 | 379,365 | 9,104,760 | 0 | Dec 21, 2018, 12:47 PM |
Low Philip S | Chief Science Officer | Dec 21, 2018 | Option Exercise | $24.00 | 409,944 | 9,838,656 | 0 | Dec 21, 2018, 12:47 PM |
Low Philip S | Chief Science Officer | Dec 21, 2018 | Option Exercise | $24.00 | 132,473 | 3,179,352 | 0 | Dec 21, 2018, 12:47 PM |
Andriole Michael T. | Chief Financial Officer | Dec 21, 2018 | Option Exercise | $24.00 | 152,582 | 3,661,968 | 0 | Dec 21, 2018, 12:46 PM |
Taylor Beth | VP Finance & Chief Acctg Offcr | Dec 17, 2018 | Option Exercise | $4.31 | 48,854 | 210,509 | 105,195 | Dec 19, 2018, 04:30 PM |
Leamon Christopher P | Vice President of Research | Dec 17, 2018 | Option Exercise | $5.14 | 101,774 | 523,489 | 224,256 | Dec 19, 2018, 04:14 PM |
Andriole Michael T. | Chief Financial Officer | Dec 17, 2018 | Option Exercise | $2.22 | 25,000 | 55,500 | 157,082 | Dec 19, 2018, 04:14 PM |
Armour Alison A. | Chief Medical Officer | Dec 17, 2018 | Option Exercise | $4.59 | 49,213 | 225,796 | 150,253 | Dec 19, 2018, 04:13 PM |
Sherman Michael A. | President and CEO | Dec 17, 2018 | Option Exercise | $6.52 | 115,559 | 753,783 | 463,477 | Dec 19, 2018, 04:13 PM |
Low Philip S | Chief Science Officer | Dec 17, 2018 | Option Exercise | $5.52 | 140,214 | 774,202 | 409,944 | Dec 19, 2018, 04:13 PM |
Low Philip S | Chief Science Officer | Oct 05, 2018 | Sale | $15.56 | 5,928 | 92,238 | 321,550 | Oct 16, 2018, 04:18 PM |
Parker Katherine | VP of Human Resources | Oct 05, 2018 | Sale | $15.55 | 6,771 | 105,316 | 70,869 | Oct 16, 2018, 04:17 PM |
Leamon Christopher P | Vice President of Research | Oct 05, 2018 | Sale | $15.56 | 9,028 | 140,437 | 122,219 | Oct 16, 2018, 04:17 PM |
Armour Alison A. | Chief Medical Officer | Oct 05, 2018 | Sale | $15.56 | 9,111 | 141,748 | 101,040 | Oct 09, 2018, 02:21 PM |
Leamon Christopher P | Vice President of Research | Oct 05, 2018 | Sale | $15.56 | 9,028 | 140,437 | 121,353 | Oct 09, 2018, 02:20 PM |
Taylor Beth | VP Finance & Chief Acctg Offcr | Oct 05, 2018 | Sale | $15.56 | 7,022 | 109,287 | 56,341 | Oct 09, 2018, 02:20 PM |
Sherman Michael A. | President and CEO | Oct 05, 2018 | Sale | $15.55 | 28,146 | 437,752 | 347,918 | Oct 09, 2018, 02:18 PM |
Andriole Michael T. | Chief Financial Officer | Oct 05, 2018 | Sale | $15.55 | 17,283 | 268,783 | 132,717 | Oct 09, 2018, 02:16 PM |
Andriole Michael T. | Chief Financial Officer | Oct 09, 2018 | Sale | $15.85 | 635 | 10,065 | 132,082 | Oct 09, 2018, 02:16 PM |
Chelius Erik C. | Vice President CMC | Oct 05, 2018 | Sale | $15.56 | 4,514 | 70,243 | 49,895 | Oct 09, 2018, 02:16 PM |
Parker Katherine | VP of Human Resources | Oct 05, 2018 | Sale | $15.55 | 6,771 | 105,316 | 70,349 | Oct 09, 2018, 02:14 PM |
Low Philip S | Chief Science Officer | Oct 05, 2018 | Sale | $15.56 | 5,928 | 92,238 | 319,817 | Oct 09, 2018, 02:14 PM |
Leamon Christopher P | Vice President of Research | Aug 29, 2018 | Option Exercise | $2.54 | 4,696 | 11,928 | 135,077 | Aug 29, 2018, 05:20 PM |
Leamon Christopher P | Vice President of Research | Aug 28, 2018 | Option Exercise | $2.54 | 12,670 | 32,182 | 143,051 | Aug 29, 2018, 05:20 PM |
Leamon Christopher P | Vice President of Research | Aug 29, 2018 | Sale | $20.00 | 4,696 | 93,920 | 130,381 | Aug 29, 2018, 05:20 PM |
Leamon Christopher P | Vice President of Research | Aug 28, 2018 | Sale | $20.00 | 12,670 | 253,403 | 130,381 | Aug 29, 2018, 05:20 PM |
Taylor Beth | VP Finance & Chief Acctg Offcr | Aug 28, 2018 | Sale | $20.00 | 7,892 | 157,840 | 63,363 | Aug 29, 2018, 02:51 PM |
Taylor Beth | VP Finance & Chief Acctg Offcr | Aug 20, 2018 | Sale | $18.20 | 285 | 5,187 | 71,255 | Aug 22, 2018, 10:29 AM |
Armour Alison A. | Chief Medical Officer | Aug 01, 2018 | Sale | $15.98 | 1,414 | 22,589 | 110,151 | Aug 02, 2018, 04:05 PM |
Leamon Christopher P | Vice President of Research | Jun 12, 2018 | Sale | $15.06 | 13,089 | 197,058 | 130,381 | Jun 13, 2018, 03:30 PM |
Leamon Christopher P | Vice President of Research | Mar 09, 2018 | Sale | $9.07 | 5,036 | 45,677 | 143,470 | Mar 12, 2018, 01:33 PM |
MIDDLETON FRED A | Director | Feb 28, 2018 | Option Exercise | $4.20 | 119,048 | 500,002 | 904,465 | Mar 01, 2018, 04:27 PM |
MIDDLETON FRED A | Director | Feb 28, 2018 | Option Exercise | $4.20 | 380,952 | 1,599,998 | 1,212,413 | Mar 01, 2018, 04:27 PM |
Taylor Beth | VP Finance & Chief Acctg Offcr | Feb 06, 2018 | Option Exercise | $3.00 | 484 | 1,452 | 59,040 | Feb 08, 2018, 04:47 PM |
Leamon Christopher P | Vice President of Research | Feb 06, 2018 | Option Exercise | $3.00 | 638 | 1,914 | 126,006 | Feb 08, 2018, 04:44 PM |
Leamon Christopher P | Vice President of Research | Feb 02, 2018 | Option Exercise | $3.12 | 1,487 | 4,639 | 128,380 | Feb 06, 2018, 12:03 PM |
Leamon Christopher P | Vice President of Research | Feb 04, 2018 | Option Exercise | $3.12 | 1,736 | 5,416 | 126,644 | Feb 06, 2018, 12:03 PM |
Taylor Beth | VP Finance & Chief Acctg Offcr | Feb 04, 2018 | Option Exercise | $3.12 | 869 | 2,711 | 59,524 | Feb 06, 2018, 12:02 PM |
Taylor Beth | VP Finance & Chief Acctg Offcr | Feb 02, 2018 | Option Exercise | $3.12 | 890 | 2,777 | 60,393 | Feb 06, 2018, 12:02 PM |
Sherman Michael A. | President and CEO | Feb 02, 2018 | Option Exercise | $3.06 | 5,453 | 16,686 | 338,564 | Feb 06, 2018, 12:01 PM |
Low Philip S | Chief Science Officer | Dec 28, 2017 | Option Exercise | $3.06 | 65,445 | 200,262 | 354,050 | Jan 02, 2018, 03:39 PM |
Low Philip S | Chief Science Officer | Dec 28, 2017 | Sale | $4.41 | 50,511 | 222,824 | 303,539 | Jan 02, 2018, 03:39 PM |
Leamon Christopher P | Vice President of Research | Dec 01, 2017 | Option Exercise | $3.06 | 26,178 | 80,105 | 150,579 | Dec 04, 2017, 03:56 PM |
Leamon Christopher P | Vice President of Research | Dec 01, 2017 | Sale | $5.04 | 23,231 | 116,983 | 132,385 | Dec 04, 2017, 03:56 PM |
Low Philip S | Chief Science Officer | Nov 13, 2017 | Buy | $4.84 | 5,600 | 27,104 | 288,605 | Nov 14, 2017, 03:26 PM |
Sherman Michael A. | President, CEO and CFO | May 31, 2017 | Option Exercise | $2.10 | 44,285 | 92,998 | 208,111 | Jun 02, 2017, 08:14 AM |
Leamon Christopher P | Vice President of Research | Feb 06, 2017 | Option Exercise | $2.18 | 694 | 1,513 | 81,901 | Feb 07, 2017, 07:29 PM |
Leamon Christopher P | Vice President of Research | Feb 04, 2017 | Option Exercise | $2.18 | 1,888 | 4,116 | 82,595 | Feb 07, 2017, 07:29 PM |
Brinkley Michael A. | Vice President of Quality | Feb 06, 2017 | Option Exercise | $2.18 | 578 | 1,260 | 23,486 | Feb 07, 2017, 07:27 PM |
Brinkley Michael A. | Vice President of Quality | Feb 04, 2017 | Option Exercise | $2.18 | 1,079 | 2,352 | 24,064 | Feb 07, 2017, 07:27 PM |
Sherman Michael A. | President, CEO and CFO | Feb 06, 2017 | Option Exercise | $2.18 | 692 | 1,509 | 163,826 | Feb 07, 2017, 07:26 PM |
Sherman Michael A. | President, CEO and CFO | Feb 04, 2017 | Option Exercise | $2.18 | 3,092 | 6,741 | 164,518 | Feb 07, 2017, 07:26 PM |
Armour Alison A. | Chief Medical Officer | Feb 04, 2017 | Option Exercise | $2.18 | 935 | 2,038 | 49,065 | Feb 07, 2017, 07:26 PM |
Low Philip S | Chief Science Officer | Feb 06, 2017 | Option Exercise | $2.18 | 694 | 1,513 | 248,605 | Feb 07, 2017, 07:25 PM |
Low Philip S | Chief Science Officer | Feb 04, 2017 | Option Exercise | $2.18 | 1,888 | 4,116 | 249,299 | Feb 07, 2017, 07:25 PM |
Low Philip S | Chief Science Officer | Nov 15, 2016 | Option Exercise | $2.10 | 15,706 | 32,983 | 233,687 | Nov 16, 2016, 04:01 PM |
BRAUER KEITH E | Director | Jul 27, 2016 | Option Exercise | $1.91 | 10,471 | 20,000 | 14,971 | Jul 28, 2016, 04:27 PM |
Ellis P Ron | Former Dir., Pres. and CEO | Jun 24, 2016 | Option Exercise | $3.68 | 13,528 | 49,783 | 320,040 | Jun 28, 2016, 05:07 PM |
Low Philip S | Chief Science Officer | May 10, 2016 | Buy | $3.52 | 11,375 | 40,040 | 217,981 | May 12, 2016, 04:07 PM |
Leamon Christopher P | Vice President of Research | Feb 17, 2016 | Option Exercise | $1.91 | 13,089 | 25,000 | 61,548 | Feb 18, 2016, 04:30 PM |
Taylor Beth | Corporate Controller | Feb 06, 2016 | Option Exercise | $3.02 | 525 | 1,585 | 16,482 | Feb 08, 2016, 08:49 PM |
Sherman Michael A. | COO and CFO | Feb 04, 2016 | Option Exercise | $3.18 | 1,771 | 5,632 | 125,666 | Feb 08, 2016, 08:49 PM |
Sherman Michael A. | COO and CFO | Feb 06, 2016 | Option Exercise | $3.02 | 694 | 2,096 | 124,972 | Feb 08, 2016, 08:49 PM |
Low Philip S | Chief Science Officer | Feb 06, 2016 | Option Exercise | $3.02 | 695 | 2,099 | 218,172 | Feb 08, 2016, 08:48 PM |
Low Philip S | Chief Science Officer | Feb 04, 2016 | Option Exercise | $3.18 | 1,081 | 3,438 | 218,867 | Feb 08, 2016, 08:48 PM |
Leamon Christopher P | Vice President of Research | Feb 06, 2016 | Option Exercise | $3.02 | 695 | 2,099 | 48,459 | Feb 08, 2016, 08:48 PM |
Leamon Christopher P | Vice President of Research | Feb 04, 2016 | Option Exercise | $3.18 | 1,081 | 3,438 | 49,154 | Feb 08, 2016, 08:48 PM |
Harper Scot | VP of CLINICAL OPERATIONS | Feb 06, 2016 | Option Exercise | $3.02 | 694 | 2,096 | 22,535 | Feb 08, 2016, 08:48 PM |
Harper Scot | VP of CLINICAL OPERATIONS | Feb 04, 2016 | Option Exercise | $3.18 | 1,078 | 3,428 | 23,229 | Feb 08, 2016, 08:48 PM |
Ellis P Ron | President and CEO | Feb 06, 2016 | Option Exercise | $3.02 | 2,085 | 6,297 | 330,951 | Feb 08, 2016, 08:47 PM |
Ellis P Ron | President and CEO | Feb 04, 2016 | Option Exercise | $3.18 | 3,320 | 10,558 | 333,036 | Feb 08, 2016, 08:47 PM |
Brinkley Michael A. | VP OF QUALITY | Feb 06, 2016 | Option Exercise | $3.02 | 580 | 1,752 | 14,933 | Feb 08, 2016, 08:47 PM |
Brinkley Michael A. | VP OF QUALITY | Feb 04, 2016 | Option Exercise | $3.18 | 618 | 1,965 | 15,513 | Feb 08, 2016, 08:47 PM |
MIDDLETON FRED A | Director | Jan 19, 2016 | Buy | $2.79 | 10,000 | 27,900 | 200,999 | Jan 20, 2016, 04:30 PM |
MIDDLETON FRED A | Director | Jan 15, 2016 | Buy | $2.80 | 20,000 | 56,000 | 190,999 | Jan 20, 2016, 04:30 PM |
Low Philip S | Chief Science Officer | Dec 24, 2015 | Option Exercise | $1.91 | 13,089 | 25,000 | 211,198 | Dec 28, 2015, 04:00 PM |
Nguyen Binh | VP of Medical Affairs | Mar 03, 2015 | Option Exercise | $3.55 | 40,000 | 142,000 | 58,242 | Mar 05, 2015, 04:30 PM |
Nguyen Binh | VP of Medical Affairs | Mar 03, 2015 | Sale | $5.79 | 29,883 | 172,987 | 28,359 | Mar 05, 2015, 04:30 PM |
Low Philip S | Chief Science Officer | Feb 10, 2015 | Option Exercise | $1.91 | 544 | 1,039 | 198,109 | Feb 26, 2015, 06:32 PM |
Leamon Christopher P | Vice President of Research | Feb 10, 2015 | Option Exercise | $1.91 | 13,089 | 25,000 | 39,855 | Feb 26, 2015, 06:31 PM |
Ellis P Ron | President and CEO | Feb 06, 2015 | Option Exercise | $5.21 | 52,356 | 272,775 | 305,196 | Feb 26, 2015, 06:30 PM |
Taylor Beth | Corporate Controller | Feb 06, 2015 | Option Exercise | $5.14 | 525 | 2,698 | 11,627 | Feb 06, 2015, 08:02 PM |
Sherman Michael A. | COO and CFO | Feb 06, 2015 | Option Exercise | $5.14 | 693 | 3,562 | 110,909 | Feb 06, 2015, 08:02 PM |
Nguyen Binh | VP of Medical Affairs | Feb 06, 2015 | Option Exercise | $5.14 | 708 | 3,639 | 18,242 | Feb 06, 2015, 08:02 PM |
Leamon Christopher P | Vice President of Research | Feb 06, 2015 | Option Exercise | $5.14 | 695 | 3,572 | 26,766 | Feb 06, 2015, 08:01 PM |
Harper Scot | VP of CLINICAL OPERATIONS | Feb 06, 2015 | Option Exercise | $5.14 | 693 | 3,562 | 15,557 | Feb 06, 2015, 08:01 PM |
Brinkley Michael A. | VP OF QUALITY | Feb 06, 2015 | Option Exercise | $5.14 | 579 | 2,976 | 10,936 | Feb 06, 2015, 08:00 PM |
Ellis P Ron | President and CEO | Nov 05, 2014 | Option Exercise | $1.91 | 19,060 | 36,405 | 225,965 | Nov 07, 2014, 02:17 PM |
Sherman Michael A. | COO and CFO | Oct 31, 2014 | Option Exercise | $2.48 | 14,927 | 36,973 | 96,391 | Nov 04, 2014, 05:00 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Aug 11, 2014 | Option Exercise | $3.54 | 21,479 | 76,016 | 27,729 | Aug 13, 2014, 05:00 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Aug 11, 2014 | Sale | $7.00 | 21,479 | 150,353 | 6,250 | Aug 13, 2014, 05:00 PM |
Ritter Allen R | VP of Manufacturing/CMC | Apr 10, 2014 | Option Exercise | $2.53 | 22,560 | 56,976 | 34,282 | Apr 11, 2014, 05:12 PM |
Ritter Allen R | VP of Manufacturing/CMC | Apr 09, 2014 | Sale | $21.16 | 1,000 | 21,160 | 11,722 | Apr 11, 2014, 05:12 PM |
Ritter Allen R | VP of Manufacturing/CMC | Mar 21, 2014 | Sale | $33.11 | 8,000 | 264,880 | 12,722 | Mar 24, 2014, 04:00 PM |
Ellis P Ron | President and CEO | Mar 10, 2014 | Option Exercise | $1.91 | 80,000 | 152,800 | 204,586 | Mar 12, 2014, 07:31 PM |
Low Philip S | Chief Science Officer | Feb 14, 2014 | Sale | $15.00 | 6,000 | 90,000 | 200,819 | Feb 18, 2014, 05:00 PM |
Low Philip S | Chief Science Officer | Feb 11, 2014 | Option Exercise | $1.91 | 1,000 | 1,910 | 206,819 | Feb 13, 2014, 05:10 PM |
Low Philip S | Chief Science Officer | Oct 15, 2013 | Option Exercise | $1.91 | 1,000 | 1,910 | 195,319 | Jan 27, 2014, 06:00 PM |
Low Philip S | Chief Science Officer | Jan 14, 2014 | Option Exercise | $1.91 | 1,000 | 1,910 | 198,319 | Jan 16, 2014, 06:28 PM |
Low Philip S | Chief Science Officer | Dec 17, 2013 | Option Exercise | $1.91 | 1,000 | 1,910 | 197,319 | Dec 19, 2013, 04:52 PM |
Ellis P Ron | President and CEO | Dec 04, 2013 | Option Exercise | $1.91 | 3,000 | 5,730 | 29,154 | Dec 04, 2013, 05:24 PM |
Ellis P Ron | President and CEO | Dec 02, 2013 | Sale | $12.00 | 3,000 | 36,000 | 26,154 | Dec 04, 2013, 05:24 PM |
Low Philip S | Chief Science Officer | Nov 12, 2013 | Option Exercise | $1.91 | 1,000 | 1,910 | 196,319 | Nov 14, 2013, 04:41 PM |
Ellis P Ron | President and CEO | Nov 07, 2013 | Option Exercise | $1.91 | 3,000 | 5,730 | 29,154 | Nov 08, 2013, 04:20 PM |
Ellis P Ron | President and CEO | Nov 06, 2013 | Sale | $12.00 | 3,000 | 36,000 | 26,154 | Nov 08, 2013, 04:20 PM |
Low Philip S | Chief Science Officer | Oct 15, 2013 | Option Exercise | $1.91 | 1,000 | 1,910 | 195,319 | Oct 17, 2013, 04:15 PM |
Ellis P Ron | President and CEO | Oct 02, 2013 | Option Exercise | $1.91 | 3,000 | 5,730 | 29,154 | Oct 02, 2013, 05:21 PM |
Ellis P Ron | President and CEO | Oct 01, 2013 | Sale | $13.30 | 3,000 | 39,900 | 26,154 | Oct 02, 2013, 05:21 PM |
Low Philip S | Chief Science Officer | Sep 24, 2013 | Option Exercise | $1.91 | 1,000 | 1,910 | 194,319 | Sep 26, 2013, 09:44 PM |
Ritter Allen R | VP of Manufacturing/CMC | Sep 16, 2013 | Sale | $17.06 | 2,000 | 34,120 | 15,722 | Sep 17, 2013, 04:22 PM |
Meek David D. | Chief Commercial Officer | Sep 12, 2013 | Option Exercise | $8.73 | 10,000 | 87,300 | 10,000 | Sep 16, 2013, 07:55 PM |
Meek David D. | Chief Commercial Officer | Sep 12, 2013 | Sale | $15.50 | 10,000 | 155,000 | 0 | Sep 16, 2013, 07:55 PM |
Ellis P Ron | President and CEO | Sep 04, 2013 | Option Exercise | $1.91 | 3,000 | 5,730 | 29,154 | Sep 05, 2013, 04:31 PM |
Ellis P Ron | President and CEO | Sep 03, 2013 | Sale | $14.54 | 3,000 | 43,620 | 26,154 | Sep 05, 2013, 04:31 PM |
Ritter Allen R | VP of Manufacturing/CMC | Aug 30, 2013 | Option Exercise | $2.10 | 6,000 | 12,600 | 23,722 | Sep 04, 2013, 04:00 PM |
Ritter Allen R | VP of Manufacturing/CMC | Aug 30, 2013 | Sale | $14.36 | 6,000 | 86,160 | 17,722 | Sep 04, 2013, 04:00 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Aug 06, 2013 | Option Exercise | $2.99 | 7,000 | 20,906 | 7,000 | Aug 08, 2013, 07:01 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Aug 06, 2013 | Sale | $17.29 | 7,000 | 121,030 | 0 | Aug 08, 2013, 07:01 PM |
Ellis P Ron | President and CEO | Aug 02, 2013 | Option Exercise | $1.91 | 3,000 | 5,730 | 29,154 | Aug 06, 2013, 04:38 PM |
Ellis P Ron | President and CEO | Aug 01, 2013 | Sale | $18.12 | 3,000 | 54,360 | 26,154 | Aug 06, 2013, 04:38 PM |
Ellis P Ron | President and CEO | Jul 16, 2013 | Option Exercise | $1.91 | 3,000 | 5,730 | 29,154 | Jul 17, 2013, 04:32 PM |
Ellis P Ron | President and CEO | Jul 15, 2013 | Sale | $17.01 | 3,000 | 51,030 | 26,154 | Jul 17, 2013, 04:32 PM |
HANHAM ANN | Director | May 28, 2013 | Sale | $14.25 | 131 | 1,867 | 54,165 | May 29, 2013, 04:20 PM |
HANHAM ANN | Director | May 24, 2013 | Sale | $14.07 | 630 | 8,864 | 54,296 | May 29, 2013, 04:20 PM |
HANHAM ANN | Director | May 28, 2013 | Sale | $14.25 | 1,569 | 22,358 | 651,270 | May 29, 2013, 04:20 PM |
HANHAM ANN | Director | May 24, 2013 | Sale | $14.07 | 7,570 | 106,510 | 652,839 | May 29, 2013, 04:20 PM |
Ritter Allen R | VP of Manufacturing/CMC | May 23, 2013 | Option Exercise | $2.10 | 5,000 | 10,500 | 17,722 | May 23, 2013, 04:50 PM |
Nguyen Binh | VP of Clinical Affairs | May 22, 2013 | Option Exercise | $3.55 | 2,700 | 9,585 | 2,700 | May 23, 2013, 04:47 PM |
HANHAM ANN | Director | May 20, 2013 | Sale | $14.42 | 11,633 | 167,748 | 685,705 | May 22, 2013, 06:30 PM |
HANHAM ANN | Director | May 22, 2013 | Sale | $14.39 | 1,259 | 18,117 | 54,926 | May 22, 2013, 06:30 PM |
HANHAM ANN | Director | May 21, 2013 | Sale | $14.31 | 845 | 12,092 | 56,185 | May 22, 2013, 06:30 PM |
HANHAM ANN | Director | May 20, 2013 | Sale | $14.42 | 967 | 13,944 | 57,030 | May 22, 2013, 06:30 PM |
HANHAM ANN | Director | May 22, 2013 | Sale | $14.39 | 15,141 | 217,879 | 660,409 | May 22, 2013, 06:30 PM |
HANHAM ANN | Director | May 21, 2013 | Sale | $14.31 | 10,155 | 145,318 | 675,550 | May 22, 2013, 06:30 PM |
Ritter Allen R | VP of Manufacturing/CMC | May 21, 2013 | Sale | $14.17 | 483 | 6,844 | 12,722 | May 22, 2013, 04:02 PM |
Nguyen Binh | VP of Clinical Affairs | May 17, 2013 | Option Exercise | $3.55 | 17,300 | 61,415 | 17,300 | May 21, 2013, 05:46 PM |
Nguyen Binh | VP of Clinical Affairs | May 17, 2013 | Sale | $14.42 | 17,300 | 249,466 | 0 | May 21, 2013, 05:46 PM |
HANHAM ANN | Director | May 17, 2013 | Sale | $14.37 | 1,121 | 16,109 | 57,997 | May 20, 2013, 04:38 PM |
HANHAM ANN | Director | May 16, 2013 | Sale | $14.44 | 1,735 | 25,053 | 59,118 | May 20, 2013, 04:38 PM |
HANHAM ANN | Director | May 17, 2013 | Sale | $14.37 | 13,479 | 193,693 | 697,338 | May 20, 2013, 04:38 PM |
HANHAM ANN | Director | May 16, 2013 | Sale | $14.44 | 20,865 | 301,291 | 710,817 | May 20, 2013, 04:38 PM |
HANHAM ANN | Director | May 15, 2013 | Sale | $14.43 | 1,536 | 22,164 | 60,853 | May 16, 2013, 05:16 PM |
HANHAM ANN | Director | May 14, 2013 | Sale | $14.94 | 1,551 | 23,172 | 62,389 | May 16, 2013, 05:16 PM |
HANHAM ANN | Director | May 15, 2013 | Sale | $14.43 | 18,464 | 266,436 | 731,682 | May 16, 2013, 05:16 PM |
HANHAM ANN | Director | May 14, 2013 | Sale | $14.94 | 18,649 | 278,616 | 750,146 | May 16, 2013, 05:16 PM |
Leamon Christopher P | Vice President of Research | May 14, 2013 | Sale | $14.70 | 5,000 | 73,500 | 10,073 | May 16, 2013, 04:34 PM |
Ritter Allen R | VP of Manufacturing/CMC | May 07, 2013 | Sale | $13.51 | 500 | 6,755 | 13,205 | May 08, 2013, 04:32 PM |
Ellis P Ron | President and CEO | May 01, 2013 | Sale | $13.88 | 500 | 6,940 | 29,154 | May 03, 2013, 04:34 PM |
Ritter Allen R | VP of Manufacturing/CMC | Apr 16, 2013 | Sale | $13.22 | 500 | 6,610 | 13,705 | Apr 18, 2013, 06:00 PM |
Ellis P Ron | President and CEO | Apr 01, 2013 | Sale | $12.54 | 500 | 6,270 | 29,654 | Apr 03, 2013, 09:01 PM |
Ritter Allen R | VP of Manufacturing/CMC | Apr 02, 2013 | Sale | $12.48 | 500 | 6,240 | 14,205 | Apr 03, 2013, 09:00 PM |
Ellis P Ron | President and CEO | Mar 27, 2013 | Sale | $12.00 | 1,500 | 18,000 | 30,154 | Mar 29, 2013, 07:01 PM |
Ellis P Ron | President and CEO | Dec 31, 2012 | Sale | $8.75 | 6,000 | 52,500 | 31,654 | Mar 29, 2013, 06:45 PM |
Ritter Allen R | VP of Manufacturing/CMC | Mar 25, 2013 | Sale | $11.00 | 1,000 | 11,000 | 14,705 | Mar 27, 2013, 04:46 PM |
Ritter Allen R | VP of Manufacturing/CMC | Mar 13, 2013 | Option Exercise | $1.91 | 12,722 | 24,299 | 15,705 | Mar 18, 2013, 09:30 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Feb 25, 2013 | Option Exercise | $3.02 | 2,102 | 6,356 | 1,993 | Feb 26, 2013, 05:16 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Feb 25, 2013 | Sale | $9.70 | 2,102 | 20,389 | 0 | Feb 26, 2013, 05:16 PM |
Ritter Allen R | VP of Manufacturing/CMC | Feb 19, 2013 | Sale | $10.03 | 500 | 5,015 | 2,983 | Feb 20, 2013, 04:16 PM |
Ritter Allen R | VP of Manufacturing/CMC | Feb 15, 2013 | Sale | $10.00 | 500 | 5,000 | 3,483 | Feb 20, 2013, 04:16 PM |
Ritter Allen R | VP of Manufacturing/CMC | Jan 31, 2013 | Sale | $10.00 | 1,000 | 10,000 | 3,983 | Feb 04, 2013, 04:11 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Jan 25, 2013 | Option Exercise | $2.92 | 2,209 | 6,457 | 1,659 | Jan 29, 2013, 06:15 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Jan 25, 2013 | Sale | $9.56 | 2,209 | 21,118 | 0 | Jan 29, 2013, 06:15 PM |
Ellis P Ron | President and CEO | Dec 31, 2012 | Sale | $8.75 | 6,000 | 52,500 | 31,654 | Jan 03, 2013, 01:00 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Dec 26, 2012 | Option Exercise | $2.54 | 2,209 | 5,611 | 2,102 | Dec 28, 2012, 04:07 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Dec 26, 2012 | Sale | $9.05 | 2,209 | 19,991 | 0 | Dec 28, 2012, 04:07 PM |
Ritter Allen R | VP of Manufacturing/CMC | Dec 18, 2012 | Sale | $9.65 | 2,000 | 19,300 | 4,983 | Dec 20, 2012, 02:55 PM |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | Dec 21, 2011 | Buy | $3.16 | 1,589 | 5,021 | 33,944 | Dec 12, 2012, 05:13 PM |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | Dec 20, 2011 | Buy | $3.20 | 1,589 | 5,085 | 32,355 | Dec 12, 2012, 05:13 PM |
Ritter Allen R | VP of Manufacturing/CMC | Nov 26, 2012 | Sale | $9.00 | 2,000 | 18,000 | 6,983 | Nov 27, 2012, 04:26 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Nov 26, 2012 | Option Exercise | $2.54 | 2,209 | 5,611 | 1,926 | Nov 27, 2012, 04:18 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Nov 26, 2012 | Sale | $8.72 | 2,209 | 19,262 | 0 | Nov 27, 2012, 04:18 PM |
Ritter Allen R | VP of Manufacturing/CMC | Nov 01, 2012 | Sale | $9.40 | 5,000 | 47,000 | 8,983 | Nov 05, 2012, 05:46 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Oct 25, 2012 | Option Exercise | $2.54 | 2,209 | 5,611 | 2,209 | Oct 29, 2012, 07:04 AM |
Lovejoy Chandra D | VP of Regulatory Affairs | Oct 25, 2012 | Sale | $9.71 | 2,209 | 21,449 | 0 | Oct 29, 2012, 07:04 AM |
Low Philip S | Chief Science Officer | Sep 28, 2012 | Sale | $9.99 | 34,000 | 339,810 | 385,117 | Oct 01, 2012, 04:12 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Sep 25, 2012 | Option Exercise | $2.54 | 2,209 | 5,611 | 2,209 | Sep 27, 2012, 04:29 PM |
Lovejoy Chandra D | VP of Regulatory Affairs | Sep 25, 2012 | Sale | $10.28 | 2,209 | 22,709 | 0 | Sep 27, 2012, 04:29 PM |
Leamon Christopher P | Vice President of Research | Aug 16, 2012 | Sale | $9.65 | 10,000 | 96,535 | 15,073 | Aug 17, 2012, 04:41 PM |
HANHAM ANN | Director | Jun 06, 2012 | Sale | $6.60 | 24,181 | 159,674 | 63,940 | Jun 07, 2012, 04:18 PM |
HANHAM ANN | Director | Jun 05, 2012 | Sale | $6.60 | 783 | 5,170 | 88,121 | Jun 07, 2012, 04:18 PM |
HANHAM ANN | Director | Jun 06, 2012 | Sale | $6.60 | 290,719 | 1,919,705 | 768,795 | Jun 07, 2012, 04:18 PM |
HANHAM ANN | Director | Jun 05, 2012 | Sale | $6.60 | 9,417 | 62,180 | 1,059,514 | Jun 07, 2012, 04:18 PM |
HANHAM ANN | Director | May 16, 2012 | Sale | $6.65 | 2,142 | 14,246 | 88,904 | Jun 04, 2012, 05:11 PM |
HANHAM ANN | Director | May 16, 2012 | Sale | $6.65 | 25,758 | 171,306 | 1,068,931 | Jun 04, 2012, 05:11 PM |
HANHAM ANN | Director | May 16, 2012 | Sale | $6.65 | 25,758 | 171,306 | 1,105,860 | May 18, 2012, 04:09 PM |
HANHAM ANN | Director | May 16, 2012 | Sale | $6.65 | 2,142 | 14,246 | 91,975 | May 18, 2012, 04:09 PM |
HANHAM ANN | Director | May 15, 2012 | Sale | $6.68 | 36,929 | 246,638 | 1,094,689 | May 16, 2012, 05:48 PM |
HANHAM ANN | Director | May 14, 2012 | Sale | $6.94 | 98,785 | 685,113 | 1,131,618 | May 16, 2012, 05:48 PM |
HANHAM ANN | Director | May 15, 2012 | Sale | $6.68 | 3,071 | 20,510 | 91,046 | May 16, 2012, 05:48 PM |
HANHAM ANN | Director | May 14, 2012 | Sale | $6.94 | 8,215 | 56,974 | 94,117 | May 16, 2012, 05:48 PM |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | Dec 21, 2011 | Buy | $3.16 | 22,200 | 70,152 | 75,166 | Jan 11, 2012, 05:12 PM |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | Dec 20, 2011 | Buy | $3.20 | 22,200 | 71,040 | 52,966 | Jan 11, 2012, 05:12 PM |
Sanderling Venture Partners V, LP | 10% Owner | Dec 21, 2011 | Buy | $3.16 | 197,800 | 625,048 | 831,461 | Jan 11, 2012, 05:11 PM |
Sanderling Venture Partners V, LP | 10% Owner | Dec 20, 2011 | Buy | $3.20 | 197,800 | 632,960 | 633,661 | Jan 11, 2012, 05:11 PM |
MIDDLETON FRED A | Director | Dec 20, 2011 | Buy | $3.18 | 916 | 2,913 | 75,000 | Dec 22, 2011, 08:34 PM |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | Dec 21, 2011 | Buy | $3.16 | 2,200 | 6,952 | 35,166 | Dec 22, 2011, 08:29 PM |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | Dec 20, 2011 | Buy | $3.20 | 2,200 | 7,040 | 32,966 | Dec 22, 2011, 08:29 PM |
Sanderling Venture Partners V, LP | 10% Owner | Dec 21, 2011 | Buy | $3.16 | 217,800 | 688,248 | 871,461 | Dec 22, 2011, 08:28 PM |
Sanderling Venture Partners V, LP | 10% Owner | Dec 20, 2011 | Buy | $3.20 | 217,800 | 696,960 | 653,661 | Dec 22, 2011, 08:28 PM |
MIDDLETON FRED A | Director | Dec 19, 2011 | Buy | $3.13 | 24,084 | 75,383 | 74,084 | Dec 21, 2011, 05:55 PM |
Leamon Christopher P | Vice President of Research | Dec 21, 2011 | Buy | $3.14 | 5,000 | 15,700 | 25,073 | Dec 21, 2011, 05:54 PM |
MIDDLETON FRED A | Director | Dec 16, 2011 | Buy | $3.16 | 50,000 | 158,000 | 50,000 | Dec 19, 2011, 03:37 PM |
BAILEY DOUGLAS G | Director | Dec 16, 2011 | Buy | $3.36 | 125,000 | 420,000 | 198,297 | Dec 16, 2011, 07:26 PM |
Ellis P Ron | President and CEO | Dec 16, 2011 | Option Exercise | $1.79 | 21,998 | 39,430 | 37,654 | Dec 16, 2011, 05:30 PM |
APLIN JOHN C | Director | Dec 16, 2011 | Buy | $3.27 | 20,000 | 65,400 | 21,063 | Dec 16, 2011, 05:08 PM |
Low Philip S | Chief Science Officer | Dec 16, 2011 | Buy | $3.21 | 1,000 | 3,206 | 434,117 | Dec 16, 2011, 04:04 PM |
Sherman Michael A. | Chief Financial Officer | Dec 16, 2011 | Option Exercise | $1.98 | 20,942 | 41,491 | 93,217 | Dec 16, 2011, 04:00 PM |
Ellis P Ron | President and CEO | Aug 05, 2011 | Option Exercise | $0.19 | 14 | 3 | 15,656 | Aug 09, 2011, 06:06 PM |
Ritter Allen R | VP of Manufacturing/CMC | Apr 18, 2011 | Option Exercise | $1.19 | 13,983 | 16,677 | 13,983 | Apr 19, 2011, 05:30 PM |
Leamon Christopher P | Vice President of Research | Mar 24, 2011 | Option Exercise | $0.28 | 20,073 | 5,525 | 20,073 | Mar 28, 2011, 02:56 PM |
Low Philip S | Chief Science Officer | Feb 04, 2011 | Buy | $6.39 | 1,520 | 9,713 | 433,117 | Feb 22, 2011, 09:20 AM |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | Feb 04, 2011 | Buy | $6.00 | 47,916 | 287,496 | 131,685 | Feb 08, 2011, 08:34 PM |
Sanderling Venture Partners V, LP | 10% Owner | Feb 04, 2011 | Buy | $6.00 | 785,417 | 4,712,502 | 785,417 | Feb 08, 2011, 08:33 PM |
MIDDLETON FRED A | Director | Feb 07, 2011 | Buy | $6.00 | 47,916 | 287,496 | 131,685 | Feb 08, 2011, 08:32 PM |
MIDDLETON FRED A | Director | Feb 07, 2011 | Buy | $6.00 | 785,417 | 4,712,502 | 785,417 | Feb 08, 2011, 08:32 PM |
HANHAM ANN | Director | Feb 04, 2011 | Option Exercise | $6.00 | 38,392 | 230,352 | 38,392 | Feb 08, 2011, 08:17 PM |
HANHAM ANN | Director | Feb 04, 2011 | Option Exercise | $6.00 | 461,608 | 2,769,648 | 461,608 | Feb 08, 2011, 08:17 PM |
Ellis P Ron | President and CEO | Feb 04, 2011 | Buy | $6.00 | 2,500 | 15,000 | 15,642 | Feb 08, 2011, 08:15 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
MIDDLETON FRED A | Director | 12/21/2018 | 21,707,160 |
MIDDLETON FRED A | Director | 12/21/2018 | 6,419,784 |
MIDDLETON FRED A | Director | 12/21/2018 | 202,416 |
MIDDLETON FRED A | Director | 12/21/2018 | 29,097,912 |
MIDDLETON FRED A | Director | 12/21/2018 | 241,176 |
MIDDLETON FRED A | Director | 12/21/2018 | 24,415,296 |
MIDDLETON FRED A | Director | 12/21/2018 | 2,419,872 |
MIDDLETON FRED A | Director | 12/21/2018 | 2,723,736 |
MIDDLETON FRED A | Director | 12/21/2018 | 2,719,560 |
MIDDLETON FRED A | Director | 12/21/2018 | 3,892,080 |
MIDDLETON FRED A | Director | 12/21/2018 | 5,979,552 |
Machado Patrick | Director | 12/21/2018 | 169,200 |
McAvoy David R. | General Counsel | 12/21/2018 | 620,856 |
Leamon Christopher P | Vice President of Research | 12/21/2018 | 5,382,144 |
Armour Alison A. | Chief Medical Officer | 12/21/2018 | 252,000 |
Armour Alison A. | Chief Medical Officer | 12/21/2018 | 3,354,072 |
Parker Katherine | VP of Human Resources | 12/21/2018 | 28,800 |
Parker Katherine | VP of Human Resources | 12/21/2018 | 1,507,128 |
Russell Lesley | Director | 12/21/2018 | 266,400 |
Chelius Erik C. | Vice President CMC | 12/21/2018 | 1,197,480 |
APLIN JOHN C | Director | 12/21/2018 | 771,912 |
Taylor Beth | VP Finance & Chief Acctg Off | 12/21/2018 | 30,000 |
Taylor Beth | VP Finance & Chief Acctg Off | 12/21/2018 | 2,358,216 |
GODDARD COLIN | Director | 12/21/2018 | 266,400 |
Svoronos Dawn | Director | 12/21/2018 | 169,200 |
KOZIN MARC D | Director | 12/21/2018 | 266,400 |
Sherman Michael A. | President and CEO | 12/21/2018 | 478,056 |
Sherman Michael A. | President and CEO | 12/21/2018 | 9,104,760 |
Low Philip S | Chief Science Officer | 12/21/2018 | 9,838,656 |
Low Philip S | Chief Science Officer | 12/21/2018 | 3,179,352 |
Andriole Michael T. | Chief Financial Officer | 12/21/2018 | 3,661,968 |
Taylor Beth | VP Finance & Chief Acctg Offcr | 12/17/2018 | 210,509 |
Leamon Christopher P | Vice President of Research | 12/17/2018 | 523,489 |
Andriole Michael T. | Chief Financial Officer | 12/17/2018 | 55,500 |
Armour Alison A. | Chief Medical Officer | 12/17/2018 | 225,796 |
Sherman Michael A. | President and CEO | 12/17/2018 | 753,783 |
Low Philip S | Chief Science Officer | 12/17/2018 | 774,202 |
Low Philip S | Chief Science Officer | 10/05/2018 | 92,238 |
Parker Katherine | VP of Human Resources | 10/05/2018 | 105,316 |
Leamon Christopher P | Vice President of Research | 10/05/2018 | 140,437 |
Armour Alison A. | Chief Medical Officer | 10/05/2018 | 141,748 |
Leamon Christopher P | Vice President of Research | 10/05/2018 | 140,437 |
Taylor Beth | VP Finance & Chief Acctg Offcr | 10/05/2018 | 109,287 |
Sherman Michael A. | President and CEO | 10/05/2018 | 437,752 |
Andriole Michael T. | Chief Financial Officer | 10/05/2018 | 268,783 |
Andriole Michael T. | Chief Financial Officer | 10/09/2018 | 10,065 |
Chelius Erik C. | Vice President CMC | 10/05/2018 | 70,243 |
Parker Katherine | VP of Human Resources | 10/05/2018 | 105,316 |
Low Philip S | Chief Science Officer | 10/05/2018 | 92,238 |
Leamon Christopher P | Vice President of Research | 08/29/2018 | 11,928 |
Leamon Christopher P | Vice President of Research | 08/28/2018 | 32,182 |
Leamon Christopher P | Vice President of Research | 08/29/2018 | 93,920 |
Leamon Christopher P | Vice President of Research | 08/28/2018 | 253,403 |
Taylor Beth | VP Finance & Chief Acctg Offcr | 08/28/2018 | 157,840 |
Taylor Beth | VP Finance & Chief Acctg Offcr | 08/20/2018 | 5,187 |
Armour Alison A. | Chief Medical Officer | 08/01/2018 | 22,589 |
Leamon Christopher P | Vice President of Research | 06/12/2018 | 197,058 |
Leamon Christopher P | Vice President of Research | 03/09/2018 | 45,677 |
MIDDLETON FRED A | Director | 02/28/2018 | 500,002 |
MIDDLETON FRED A | Director | 02/28/2018 | 1,599,998 |
Taylor Beth | VP Finance & Chief Acctg Offcr | 02/06/2018 | 1,452 |
Leamon Christopher P | Vice President of Research | 02/06/2018 | 1,914 |
Leamon Christopher P | Vice President of Research | 02/02/2018 | 4,639 |
Leamon Christopher P | Vice President of Research | 02/04/2018 | 5,416 |
Taylor Beth | VP Finance & Chief Acctg Offcr | 02/04/2018 | 2,711 |
Taylor Beth | VP Finance & Chief Acctg Offcr | 02/02/2018 | 2,777 |
Sherman Michael A. | President and CEO | 02/02/2018 | 16,686 |
Low Philip S | Chief Science Officer | 12/28/2017 | 200,262 |
Low Philip S | Chief Science Officer | 12/28/2017 | 222,824 |
Leamon Christopher P | Vice President of Research | 12/01/2017 | 80,105 |
Leamon Christopher P | Vice President of Research | 12/01/2017 | 116,983 |
Low Philip S | Chief Science Officer | 11/13/2017 | 27,104 |
Sherman Michael A. | President, CEO and CFO | 05/31/2017 | 92,998 |
Leamon Christopher P | Vice President of Research | 02/06/2017 | 1,513 |
Leamon Christopher P | Vice President of Research | 02/04/2017 | 4,116 |
Brinkley Michael A. | Vice President of Quality | 02/06/2017 | 1,260 |
Brinkley Michael A. | Vice President of Quality | 02/04/2017 | 2,352 |
Sherman Michael A. | President, CEO and CFO | 02/06/2017 | 1,509 |
Sherman Michael A. | President, CEO and CFO | 02/04/2017 | 6,741 |
Armour Alison A. | Chief Medical Officer | 02/04/2017 | 2,038 |
Low Philip S | Chief Science Officer | 02/06/2017 | 1,513 |
Low Philip S | Chief Science Officer | 02/04/2017 | 4,116 |
Low Philip S | Chief Science Officer | 11/15/2016 | 32,983 |
BRAUER KEITH E | Director | 07/27/2016 | 20,000 |
Ellis P Ron | Former Dir., Pres. and CEO | 06/24/2016 | 49,783 |
Low Philip S | Chief Science Officer | 05/10/2016 | 40,040 |
Leamon Christopher P | Vice President of Research | 02/17/2016 | 25,000 |
Taylor Beth | Corporate Controller | 02/06/2016 | 1,585 |
Sherman Michael A. | COO and CFO | 02/04/2016 | 5,632 |
Sherman Michael A. | COO and CFO | 02/06/2016 | 2,096 |
Low Philip S | Chief Science Officer | 02/06/2016 | 2,099 |
Low Philip S | Chief Science Officer | 02/04/2016 | 3,438 |
Leamon Christopher P | Vice President of Research | 02/06/2016 | 2,099 |
Leamon Christopher P | Vice President of Research | 02/04/2016 | 3,438 |
Harper Scot | VP of CLINICAL OPERATIONS | 02/06/2016 | 2,096 |
Harper Scot | VP of CLINICAL OPERATIONS | 02/04/2016 | 3,428 |
Ellis P Ron | President and CEO | 02/06/2016 | 6,297 |
Ellis P Ron | President and CEO | 02/04/2016 | 10,558 |
Brinkley Michael A. | VP OF QUALITY | 02/06/2016 | 1,752 |
Brinkley Michael A. | VP OF QUALITY | 02/04/2016 | 1,965 |
MIDDLETON FRED A | Director | 01/19/2016 | 27,900 |
MIDDLETON FRED A | Director | 01/15/2016 | 56,000 |
Low Philip S | Chief Science Officer | 12/24/2015 | 25,000 |
Nguyen Binh | VP of Medical Affairs | 03/03/2015 | 142,000 |
Nguyen Binh | VP of Medical Affairs | 03/03/2015 | 172,987 |
Low Philip S | Chief Science Officer | 02/10/2015 | 1,039 |
Leamon Christopher P | Vice President of Research | 02/10/2015 | 25,000 |
Ellis P Ron | President and CEO | 02/06/2015 | 272,775 |
Taylor Beth | Corporate Controller | 02/06/2015 | 2,698 |
Sherman Michael A. | COO and CFO | 02/06/2015 | 3,562 |
Nguyen Binh | VP of Medical Affairs | 02/06/2015 | 3,639 |
Leamon Christopher P | Vice President of Research | 02/06/2015 | 3,572 |
Harper Scot | VP of CLINICAL OPERATIONS | 02/06/2015 | 3,562 |
Brinkley Michael A. | VP OF QUALITY | 02/06/2015 | 2,976 |
Ellis P Ron | President and CEO | 11/05/2014 | 36,405 |
Sherman Michael A. | COO and CFO | 10/31/2014 | 36,973 |
Lovejoy Chandra D | VP of Regulatory Affairs | 08/11/2014 | 76,016 |
Lovejoy Chandra D | VP of Regulatory Affairs | 08/11/2014 | 150,353 |
Ritter Allen R | VP of Manufacturing/CMC | 04/10/2014 | 56,976 |
Ritter Allen R | VP of Manufacturing/CMC | 04/09/2014 | 21,160 |
Ritter Allen R | VP of Manufacturing/CMC | 03/21/2014 | 264,880 |
Ellis P Ron | President and CEO | 03/10/2014 | 152,800 |
Low Philip S | Chief Science Officer | 02/14/2014 | 90,000 |
Low Philip S | Chief Science Officer | 02/11/2014 | 1,910 |
Low Philip S | Chief Science Officer | 10/15/2013 | 1,910 |
Low Philip S | Chief Science Officer | 01/14/2014 | 1,910 |
Low Philip S | Chief Science Officer | 12/17/2013 | 1,910 |
Ellis P Ron | President and CEO | 12/04/2013 | 5,730 |
Ellis P Ron | President and CEO | 12/02/2013 | 36,000 |
Low Philip S | Chief Science Officer | 11/12/2013 | 1,910 |
Ellis P Ron | President and CEO | 11/07/2013 | 5,730 |
Ellis P Ron | President and CEO | 11/06/2013 | 36,000 |
Low Philip S | Chief Science Officer | 10/15/2013 | 1,910 |
Ellis P Ron | President and CEO | 10/02/2013 | 5,730 |
Ellis P Ron | President and CEO | 10/01/2013 | 39,900 |
Low Philip S | Chief Science Officer | 09/24/2013 | 1,910 |
Ritter Allen R | VP of Manufacturing/CMC | 09/16/2013 | 34,120 |
Meek David D. | Chief Commercial Officer | 09/12/2013 | 87,300 |
Meek David D. | Chief Commercial Officer | 09/12/2013 | 155,000 |
Ellis P Ron | President and CEO | 09/04/2013 | 5,730 |
Ellis P Ron | President and CEO | 09/03/2013 | 43,620 |
Ritter Allen R | VP of Manufacturing/CMC | 08/30/2013 | 12,600 |
Ritter Allen R | VP of Manufacturing/CMC | 08/30/2013 | 86,160 |
Lovejoy Chandra D | VP of Regulatory Affairs | 08/06/2013 | 20,906 |
Lovejoy Chandra D | VP of Regulatory Affairs | 08/06/2013 | 121,030 |
Ellis P Ron | President and CEO | 08/02/2013 | 5,730 |
Ellis P Ron | President and CEO | 08/01/2013 | 54,360 |
Ellis P Ron | President and CEO | 07/16/2013 | 5,730 |
Ellis P Ron | President and CEO | 07/15/2013 | 51,030 |
HANHAM ANN | Director | 05/28/2013 | 1,867 |
HANHAM ANN | Director | 05/24/2013 | 8,864 |
HANHAM ANN | Director | 05/28/2013 | 22,358 |
HANHAM ANN | Director | 05/24/2013 | 106,510 |
Ritter Allen R | VP of Manufacturing/CMC | 05/23/2013 | 10,500 |
Nguyen Binh | VP of Clinical Affairs | 05/22/2013 | 9,585 |
HANHAM ANN | Director | 05/20/2013 | 167,748 |
HANHAM ANN | Director | 05/22/2013 | 18,117 |
HANHAM ANN | Director | 05/21/2013 | 12,092 |
HANHAM ANN | Director | 05/20/2013 | 13,944 |
HANHAM ANN | Director | 05/22/2013 | 217,879 |
HANHAM ANN | Director | 05/21/2013 | 145,318 |
Ritter Allen R | VP of Manufacturing/CMC | 05/21/2013 | 6,844 |
Nguyen Binh | VP of Clinical Affairs | 05/17/2013 | 61,415 |
Nguyen Binh | VP of Clinical Affairs | 05/17/2013 | 249,466 |
HANHAM ANN | Director | 05/17/2013 | 16,109 |
HANHAM ANN | Director | 05/16/2013 | 25,053 |
HANHAM ANN | Director | 05/17/2013 | 193,693 |
HANHAM ANN | Director | 05/16/2013 | 301,291 |
HANHAM ANN | Director | 05/15/2013 | 22,164 |
HANHAM ANN | Director | 05/14/2013 | 23,172 |
HANHAM ANN | Director | 05/15/2013 | 266,436 |
HANHAM ANN | Director | 05/14/2013 | 278,616 |
Leamon Christopher P | Vice President of Research | 05/14/2013 | 73,500 |
Ritter Allen R | VP of Manufacturing/CMC | 05/07/2013 | 6,755 |
Ellis P Ron | President and CEO | 05/01/2013 | 6,940 |
Ritter Allen R | VP of Manufacturing/CMC | 04/16/2013 | 6,610 |
Ellis P Ron | President and CEO | 04/01/2013 | 6,270 |
Ritter Allen R | VP of Manufacturing/CMC | 04/02/2013 | 6,240 |
Ellis P Ron | President and CEO | 03/27/2013 | 18,000 |
Ellis P Ron | President and CEO | 12/31/2012 | 52,500 |
Ritter Allen R | VP of Manufacturing/CMC | 03/25/2013 | 11,000 |
Ritter Allen R | VP of Manufacturing/CMC | 03/13/2013 | 24,299 |
Lovejoy Chandra D | VP of Regulatory Affairs | 02/25/2013 | 6,356 |
Lovejoy Chandra D | VP of Regulatory Affairs | 02/25/2013 | 20,389 |
Ritter Allen R | VP of Manufacturing/CMC | 02/19/2013 | 5,015 |
Ritter Allen R | VP of Manufacturing/CMC | 02/15/2013 | 5,000 |
Ritter Allen R | VP of Manufacturing/CMC | 01/31/2013 | 10,000 |
Lovejoy Chandra D | VP of Regulatory Affairs | 01/25/2013 | 6,457 |
Lovejoy Chandra D | VP of Regulatory Affairs | 01/25/2013 | 21,118 |
Ellis P Ron | President and CEO | 12/31/2012 | 52,500 |
Lovejoy Chandra D | VP of Regulatory Affairs | 12/26/2012 | 5,611 |
Lovejoy Chandra D | VP of Regulatory Affairs | 12/26/2012 | 19,991 |
Ritter Allen R | VP of Manufacturing/CMC | 12/18/2012 | 19,300 |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | 12/21/2011 | 5,021 |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | 12/20/2011 | 5,085 |
Ritter Allen R | VP of Manufacturing/CMC | 11/26/2012 | 18,000 |
Lovejoy Chandra D | VP of Regulatory Affairs | 11/26/2012 | 5,611 |
Lovejoy Chandra D | VP of Regulatory Affairs | 11/26/2012 | 19,262 |
Ritter Allen R | VP of Manufacturing/CMC | 11/01/2012 | 47,000 |
Lovejoy Chandra D | VP of Regulatory Affairs | 10/25/2012 | 5,611 |
Lovejoy Chandra D | VP of Regulatory Affairs | 10/25/2012 | 21,449 |
Low Philip S | Chief Science Officer | 09/28/2012 | 339,810 |
Lovejoy Chandra D | VP of Regulatory Affairs | 09/25/2012 | 5,611 |
Lovejoy Chandra D | VP of Regulatory Affairs | 09/25/2012 | 22,709 |
Leamon Christopher P | Vice President of Research | 08/16/2012 | 96,535 |
HANHAM ANN | Director | 06/06/2012 | 159,674 |
HANHAM ANN | Director | 06/05/2012 | 5,170 |
HANHAM ANN | Director | 06/06/2012 | 1,919,705 |
HANHAM ANN | Director | 06/05/2012 | 62,180 |
HANHAM ANN | Director | 05/16/2012 | 14,246 |
HANHAM ANN | Director | 05/16/2012 | 171,306 |
HANHAM ANN | Director | 05/16/2012 | 171,306 |
HANHAM ANN | Director | 05/16/2012 | 14,246 |
HANHAM ANN | Director | 05/15/2012 | 246,638 |
HANHAM ANN | Director | 05/14/2012 | 685,113 |
HANHAM ANN | Director | 05/15/2012 | 20,510 |
HANHAM ANN | Director | 05/14/2012 | 56,974 |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | 12/21/2011 | 70,152 |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | 12/20/2011 | 71,040 |
Sanderling Venture Partners V, LP | 10% Owner | 12/21/2011 | 625,048 |
Sanderling Venture Partners V, LP | 10% Owner | 12/20/2011 | 632,960 |
MIDDLETON FRED A | Director | 12/20/2011 | 2,913 |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | 12/21/2011 | 6,952 |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | 12/20/2011 | 7,040 |
Sanderling Venture Partners V, LP | 10% Owner | 12/21/2011 | 688,248 |
Sanderling Venture Partners V, LP | 10% Owner | 12/20/2011 | 696,960 |
MIDDLETON FRED A | Director | 12/19/2011 | 75,383 |
Leamon Christopher P | Vice President of Research | 12/21/2011 | 15,700 |
MIDDLETON FRED A | Director | 12/16/2011 | 158,000 |
BAILEY DOUGLAS G | Director | 12/16/2011 | 420,000 |
Ellis P Ron | President and CEO | 12/16/2011 | 39,430 |
APLIN JOHN C | Director | 12/16/2011 | 65,400 |
Low Philip S | Chief Science Officer | 12/16/2011 | 3,206 |
Sherman Michael A. | Chief Financial Officer | 12/16/2011 | 41,491 |
Ellis P Ron | President and CEO | 08/05/2011 | 3 |
Ritter Allen R | VP of Manufacturing/CMC | 04/18/2011 | 16,677 |
Leamon Christopher P | Vice President of Research | 03/24/2011 | 5,525 |
Low Philip S | Chief Science Officer | 02/04/2011 | 9,713 |
SANDERLING VENTURES MANAGEMENT V | 10% Owner | 02/04/2011 | 287,496 |
Sanderling Venture Partners V, LP | 10% Owner | 02/04/2011 | 4,712,502 |
MIDDLETON FRED A | Director | 02/07/2011 | 287,496 |
MIDDLETON FRED A | Director | 02/07/2011 | 4,712,502 |
HANHAM ANN | Director | 02/04/2011 | 230,352 |
HANHAM ANN | Director | 02/04/2011 | 2,769,648 |
Ellis P Ron | President and CEO | 02/04/2011 | 15,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...